An Chuanfeng, Zhao Yuan, Guo Lipeng, Zhang Zhijian, Yan Chunxiao, Zhang Shiying, Zhang Yujie, Shao Fei, Qi Yuanyuan, Wang Xun, Wang Huanan, Zhang Lijun
Ophthalmology and Transformational Innovation Research Center, Faculty of Medicine of Dalian University of Technology&Dalian Third People's Hospital, Dalian, 116033, PR China.
Third People's Hospital of Dalian, Dalian Eye Hospital, Dalian, 116033, PR China.
Mater Today Bio. 2025 Jan 9;31:101476. doi: 10.1016/j.mtbio.2025.101476. eCollection 2025 Apr.
Stem cell-based therapy has emerged as a promising approach for heart repair, potentially regenerating damaged heart tissue and improving outcomes for patients with heart disease. However, the efficacy of stem cell-based therapies remains limited by several challenges, including poor cell survival, low retention rates, poor integration, and limited functional outcomes. This article reviews current enhancement strategies to optimize mesenchymal stem cell therapy for cardiac repair. Key approaches include optimizing cell delivery methods, enhancing cell engraftment, promoting cell functions through genetic and molecular modifications, enhancing the paracrine effects of stem cells, and leveraging biomaterials and tissue engineering techniques. By focusing on these enhancement techniques, the paper highlights innovative approaches that can potentially transform stem cell therapy into a more viable and effective treatment option for cardiac repair. The ongoing research and technological advancements continue to push the boundaries, hoping to make stem cell therapy a mainstream treatment for heart disease.
基于干细胞的疗法已成为一种很有前景的心脏修复方法,有望使受损的心脏组织再生,并改善心脏病患者的治疗效果。然而,基于干细胞的疗法的疗效仍然受到若干挑战的限制,包括细胞存活率低、滞留率低、整合不良以及功能结果有限。本文综述了当前优化间充质干细胞治疗心脏修复的增强策略。关键方法包括优化细胞递送方法、增强细胞植入、通过基因和分子修饰促进细胞功能、增强干细胞的旁分泌作用以及利用生物材料和组织工程技术。通过关注这些增强技术,本文重点介绍了一些创新方法,这些方法有可能将干细胞治疗转变为一种更可行、更有效的心脏修复治疗选择。正在进行的研究和技术进步不断突破界限,希望使干细胞治疗成为心脏病的主流治疗方法。